Looks like medivet sale to be concluded 2Q of 2016. I guess the generous sale-window provides time to maximise the result to shareholders. I personally would prefer they knock on as many doors as possible to get the best value.
DYOR, IMO etc..
"NOTE 26 - ASSETS HELD FOR SALE
On 23 June 2015 the Company announced that it would begin exploring options to divest
entirely, or dilute its interests in its animal healthcare business. Although a significant
investment in organisational resources and R&D has been made in the Medivet business,
the Company acknowledges that it has neither the financial resources nor the know how to
fully realise the potential of the animal health business in the vast United States market.
The Company commenced activities to identify potential investors or purchasers during
July and progress is being made in the process. The transactions being pursued are a
capital raising in the U.S., leading to a dilution of the Company’s interests, or a trade sale.
Whichever process is successful, it is anticipated that a transaction will be concluded early
in the second quarter of the 2016 financial year.
The assets which could be disposed of through a trade sale (the “disposal assets”), include,
trade debtors and creditors, prepayments, inventory, fixed assets, goodwill, development
intangibles, intellectual property, trademarks and various liabilities. Should a dilution of
interests held occur, the Company would most likely no longer consolidate the accounts of
Medivet, instead present certain information as required under AASB 12."
